Annual CAPEX:
$44.00K-$105.00K(-70.47%)Summary
- As of today, ELVN annual capital expenditures is $44.00 thousand, with the most recent change of -$105.00 thousand (-70.47%) on December 31, 2024.
- During the last 3 years, ELVN annual CAPEX has fallen by -$147.00 thousand (-76.96%).
- ELVN annual CAPEX is now -87.88% below its all-time high of $363.00 thousand, reached on December 31, 2022.
Performance
ELVN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$1000.00-$138.00K(-99.28%)Summary
- As of today, ELVN quarterly capital expenditures is $1000.00, with the most recent change of -$138.00 thousand (-99.28%) on September 30, 2025.
- Over the past year, ELVN quarterly CAPEX has dropped by -$21.00 thousand (-95.45%).
- ELVN quarterly CAPEX is now -99.67% below its all-time high of $303.00 thousand, reached on June 1, 2022.
Performance
ELVN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$160.00K-$21.00K(-11.60%)Summary
- As of today, ELVN TTM capital expenditures is $160.00 thousand, with the most recent change of -$21.00 thousand (-11.60%) on September 30, 2025.
- Over the past year, ELVN TTM CAPEX has increased by +$102.00 thousand (+175.86%).
- ELVN TTM CAPEX is now -75.72% below its all-time high of $659.00 thousand, reached on December 31, 2022.
Performance
ELVN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ELVN CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -70.5% | -95.5% | +175.9% |
| 3Y3 Years | -77.0% | -92.9% | -68.7% |
| 5Y5 Years | -68.6% | +100.0% | +627.3% |
ELVN CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -87.9% | at low | -99.3% | >+9999.0% | -75.7% | +263.6% |
| 5Y | 5-Year | -87.9% | +144.4% | -99.7% | >+9999.0% | -75.7% | +1233.3% |
| All-Time | All-Time | -87.9% | >+9999.0% | -99.7% | >+9999.0% | -75.7% | +1233.3% |
ELVN CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1000.00(-99.3%) | $160.00K(-11.6%) |
| Jun 2025 | - | $139.00K(+595.0%) | $181.00K(+311.4%) |
| Mar 2025 | - | $20.00K(>+9900.0%) | $44.00K(0.0%) |
| Dec 2024 | $44.00K(-70.5%) | $0.00(-100.0%) | $44.00K(-24.1%) |
| Sep 2024 | - | $22.00K(+1000.0%) | $58.00K(+11.5%) |
| Jun 2024 | - | $2000.00(-90.0%) | $52.00K(-62.3%) |
| Mar 2024 | - | $20.00K(+42.9%) | $138.00K(-7.4%) |
| Dec 2023 | $149.00K(-59.0%) | $14.00K(-12.5%) | $149.00K(-47.3%) |
| Sep 2023 | - | $16.00K(-81.8%) | $283.00K(+0.7%) |
| Jun 2023 | - | $88.00K(+183.9%) | $281.00K(-43.3%) |
| Mar 2023 | - | $31.00K(-79.1%) | $496.00K(-24.7%) |
| Dec 2022 | $363.00K | $148.00K(+957.1%) | $659.00K(+29.0%) |
| Sep 2022 | - | $14.00K(-95.4%) | $511.00K(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $303.00K(+56.2%) | $497.00K(+156.2%) |
| Mar 2022 | - | $194.00K(>+9900.0%) | $194.00K(+1516.7%) |
| Dec 2021 | $191.00K(+961.1%) | - | - |
| Dec 2021 | - | $0.00(0.0%) | $12.00K(-25.0%) |
| Sep 2021 | - | $0.00(0.0%) | $16.00K(0.0%) |
| Jun 2021 | - | $0.00(-100.0%) | $16.00K(-30.4%) |
| Mar 2021 | - | $12.00K(+200.0%) | $23.00K(-11.5%) |
| Dec 2020 | $18.00K(-87.1%) | $4000.00(>+9900.0%) | $26.00K(+18.2%) |
| Sep 2020 | - | $0.00(-100.0%) | $22.00K(0.0%) |
| Jun 2020 | - | $7000.00(-53.3%) | $22.00K(+46.7%) |
| Mar 2020 | - | $15.00K | $15.00K |
| Dec 2019 | $140.00K(>+9900.0%) | - | - |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual CAPEX year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Enliven Therapeutics, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM CAPEX year-on-year change?
What is Enliven Therapeutics, Inc. annual capital expenditures?
The current annual CAPEX of ELVN is $44.00K
What is the all-time high annual CAPEX for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual capital expenditures is $363.00K
What is Enliven Therapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, ELVN annual capital expenditures has changed by -$105.00K (-70.47%)
What is Enliven Therapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of ELVN is $1000.00
What is the all-time high quarterly CAPEX for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly capital expenditures is $303.00K
What is Enliven Therapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, ELVN quarterly capital expenditures has changed by -$21.00K (-95.45%)
What is Enliven Therapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of ELVN is $160.00K
What is the all-time high TTM CAPEX for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM capital expenditures is $659.00K
What is Enliven Therapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, ELVN TTM capital expenditures has changed by +$102.00K (+175.86%)